Company
Glenmark Pharmaceuticals Europe Limited
Glenmark Pharmaceuticals Europe Limited is an active UK company (number 05040260), incorporated 2004, with 1 current director, Oliver Henry Bourne. Source: Companies House, updated 4th October 2026.
Official record Companies House · updated 4th October 2026 · Sources
Network
The large node is Glenmark Pharmaceuticals Europe Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.
Who leads it
Previous officers 12
- Achin Gupta 2017-2021 View profile
- Dr Alexandra May Pearce 2015-2016 View profile
- Magdalena Marlena Tomaszewska 2014-2016 View profile
- Meera Nilesh Vanjari 2013-2017 View profile
- Marshall Joseph Mendonza 2009-2013 View profile
- Rahul Garella 2008-2014 View profile
- Guy Hedley Clark 2005-2008 View profile
- Glenn Mario Saldanha 2004-2009 View profile
- Cheryl Pinto 2004-2017 View profile
- Sameer Ashok Paigankar 2004-2004 View profile
- Fiona Hill 2017-2019 View profile
- Laxmi Financial Services Limited 2004-2012 View profile
Directors and secretaries as filed at Companies House.
Do you help lead this organisation? Set up its network · How it works
Public contracts won
7 contracts · £15,529,352 totalFrom Contracts Finder and Find a Tender, the UK Government's public procurement notices, under the Open Government Licence v3.0. Matched to this organisation by company number, charity number or exact name and postcode; every figure links to its source notice.
-
NHS National Generic Pharmaceuticals - Wave 16a
NHS National Framework for Generics Pharmaceuticals Wave 16a Offer reference number: CM/PHG/24/5714 Period of framework agreement: Dates detailed below, with an option or options to extend (at the authority’s discretion) for a period or per…
Framework -
Antiviral Generic Medicines
Supply of Antiviral Generic Medicines to NHS Scotland
Framework -
Oncology Generics Medicines
This Framework Agreement is for the supply of Oncology Generic medicines to NHS Scotland. The Goods have been separated into thirty-nine (39) categories, each of which is identified as a “Lot”. Full details of each Lot is contained in secti…
Framework -
NHS National Generic Pharmaceuticals Interim 2 2020
Hospital only products - All regions:01/02/2021 to 31/01/2022Orals (plus non-parenterals) – Allregions: 01/03/2021 to 28/02/202212 months with an option or options toextend (at the Authority’s discretion) fora period or periods up to a tota…
Framework -
NP36126 Antibiotic & Genito Urinary Medicines
Supply of Antibiotic & Genito Urinary Medicines to NHS Scotland.
Framework -
NHS National Branded Interim - 1 June 2026
Provision of an NHS National Branded Interim - 1 June 2026 01/06/2026 - 30/04/2028 23 Months with an option or options to extend at the discretion of the authority up to a maximum of 25 months
Framework -
Generic, Branded Generic & Proprietary Medicinal Products - Group 18
Generic, Branded Generic & Proprietary Medicinal Products - Group 18 (6345404)
About
- Incorporated
- 10/02/2004
Board analysis
Board DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
1 directors on the board
- Oliver Henry Bourne Director · appointed 2015
Directors past 6 years
- Oliver Henry Bourne Director · appointed 2015
Gaps to watch
- A single director - no second pair of eyes on any decision
Where to look Suggested search: a second director to remove single-point control.
Sources
Official record from Companies House. Governance Register calculates the connections.
Record details
- Company number
- 05040260
- Status
- Active
- Type
- Private Limited Company
- Edition
- Register edition compiled 4th October 2026
- Labels
- Official record from Companies House · Calculated derived by Governance Register.
Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data